NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

移植用HLA型檢測市場:2021∼2027年

HLA Typing for Transplant Market 2021-2027

出版商 Orion Market Research Pvt Ltd 商品編碼 1025356
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
移植用HLA型檢測市場:2021∼2027年 HLA Typing for Transplant Market 2021-2027
出版日期: 2021年06月29日內容資訊: 英文
簡介

全球移植用人類白血球抗原(HLA)檢測的市場規模在預測期間內預計將以約6.4%的年複合成長率擴大。公私資助的增加、傳染病負擔的增加以及器官捐贈者的增加是主要因素越來越多的器官移植使用推動了HLA分型進行移植,從而推動了市場的增長,HLA分型在腎臟、肝臟、胰腺、心臟移植和骨髓移植中都有應用。

本報告提供移植用HLA型檢測市場相關調查,提供市場概要,以及科技,各類產品·服務,各用途,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 競爭情形

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
  • 重要的策略分析
  • COVID-19對主要參與者的影響

第4章 市場決策要素

  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場細分化

  • 全球移植用HLA型檢測市場,各科技
    • 非分子化驗
    • 分子化驗
    • 定序為基礎的分子化驗
  • 全球移植用HLA型檢測市場,各類產品·服務
    • 試劑
    • 軟體
    • 計量儀器
  • 全球移植用HLA型檢測市場,各用途
    • 診斷
    • 研究
  • 全球移植用HLA型檢測市場,各終端用戶
    • 學術機構及研究中心
    • 醫院及移植中心
    • 捐贈者註冊表

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 其他地區
    • 南美
    • 中東和非洲

第7章 企業簡介

  • Biofortuna Ltd.
  • Bio-Rad Laboratories, Inc
  • Biotron Healthcare Pvt. Ltd.
  • Creative-Biolabs Inc.
  • F. Hoffmann-La Roche Ltd.
  • FujirebioDiagnostics, Inc.
  • Genome Diagnostics B.V.
  • HistoGenetics LLC
  • Illumina, Inc.
  • Immucor Inc.
  • Integrated Gulf Biosystems
  • Luminex Corp.
  • MC Diagnostics Ltd.
  • Omixon Inc.
  • Pacific Biosciences of California, Inc.
  • PROIMMUNE LTD.
  • Qiagen GmbH
  • TBG Diagnostics Ltd.
  • Thermo Fisher Scientific Inc.
  • Voden Medical Instruments S.p.a.
目錄
Product Code: OMR2023770

Global HLA Typing for Transplant Market Size, Share & Trends Analysis Report By Type (Molecular Assays, and Non-Molecular Assays) By Product & Services (Reagents, Software, and Instruments) By Application (Diagnostics, and Research) By End-Users (Academic Institutes & Research Centers, Hospitals & Transplant Centers, and others) Forecast, 2021-2027

The global human leukocyte antigen (HLA) typing for the transplant market is anticipated to grow at a CAGR of around 6.4% during the forecast period. The increasing public-private funding, rising burden of infectious diseases, and growing organ donors are the major factors that are driving the use of HLA typing for transplant, which is driving the growth of the market. HLA typing found its use in the transplantation of kidney, liver, pancreas, heart transplant, and bone marrow. The increasing number of organ transplant by using molecular diagnostic assays such as PCR-based, and Next-generation sequencing (NGS) technologies, due to the growing geriatric population is the factor that is accelerating the demand for HLA typing, thus accelerating the market growth. As per the Population Reference Bureau report, the number of Americans aged above 65 years is estimated to more than double from 46 million in 2016 to reach over 98 million by 2060. HLA typing is an effective method that reduces the chance of transplant failures before the surgery to avoid any kind of loss. Moreover, the high cost of typing devices and stringent reimbursement policies are some factors limiting the growth of the global HLA Typing.

However, the technological advancements in the field of cost-effective transplant diagnostics are expected to create lucrative opportunities in the market during the forecast period. The global HLA typing for transplant market is hardly hit by the impact of the COVID-19 pandemic. The delay in transplant procedures and lack of organ donors due to the lockdown had negatively impacted the market. The disruption in the supply chain and production unit for diagnostic products and devices has also hampered the market. Many manufacturers have faced a decline in revenue. Post COVID-19, the market is expected to regain its momentum by the declining number of cases.

The HLA typing for transplant market is segmented based on technology, product & services, application, and end-users. Based on technology, the market can be diversified into non-molecular assays and molecular assays. The molecular assay segment is expected to hold the largest share during the forecast period owing to the increasing use of molecular assays such as PCR-based molecular in organ transplants due to the advantages such as real-time sample analysis, the higher degree of accuracy, faster results provided by them. Based on product & services, the market is bifurcated into reagents, software, and instruments. Based on applications, the market is segmented into diagnostics and research. Based on end-users, the market is segmented into academic institutes & research centers, hospitals & transplant centers, and donor registries.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia-Pacific is projected to witness the fastest growth in the global HLA typing for transplant market. The factors attributing to the growth of the HLA typing for transplant market in the Asia-Pacific region include the increasing geriatric population with organ failure and growing awareness about organ transplantation and organ donations. Whereas, North America dominated the market, and it is further expected to maintain its dominance during the forecast period. The factors attributing to the growth of the region include the increasing demand for organ transplants and the rising number of organ donors in the region. The presence of major market players, increasing disposable incomes, and large patients pool are also boosting the regional economy by enhancing the market growth. The key players of the market include Biofortuna Ltd., Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche Ltd., Illumina, Inc., Luminex Corp., Qiagen GmbH, Thermo Fisher Scientific Inc., among others.

Research Methodology

The market study of the global HLA typing for transplant market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.

Whitepapers, research papers, and news blogs.

Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global HLA typing for transplant Market Research and Analysis by Type

Global HLA typing for transplant Market Research and Analysis by Product & Services

Global HLA typing for transplant Market Research and Analysis by Application

Global HLA typing for transplant Market Research and Analysis by End-Users.

The Report Covers

Comprehensive research methodology of the global HLA typing for transplant market.

This report also includes a detailed and extensive market overview with key analyst insights.

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the global HLA typing for transplant market.

Insights about market determinants that are stimulating the global HLA typing for the transplant market.

Detailed and extensive market segments with the regional distribution of forecasted revenues.

Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global HLA Typing for Transplant Industry
  • Recovery Scenario of Global HLA Typing for Transplant Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19on key players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global HLA Typing for Transplant Market, Technology
    • 5.1.1. Non-Molecular Assays
        • 5.1.1.1.1. Serological Assays
        • 5.1.1.1.2. Mixed Lymphocyte Culture Assays
    • 5.1.2. Molecular Assays
      • 5.1.2.1. PCR-Based Molecular Assay
        • 5.1.2.1.1. Sequence-Specific Primer (SSP-PCR)
        • 5.1.2.1.2. Sequence-Specific Oligonucleotide (SSO-PCR)
        • 5.1.2.1.3. Sequence-Based Typing (SBT-PCR)
        • 5.1.2.1.4. Others
    • 5.1.3. Sequencing-Based Molecular Assays
        • 5.1.3.1.1. Sanger Sequencing
        • 5.1.3.1.2. Next-Generation Sequencing
  • 5.2. Global HLA Typing for Transplant Market, By Product & Services
    • 5.2.1. Reagents
    • 5.2.2. Software
    • 5.2.3. Instruments
  • 5.3. Global HLA Typing for Transplant Market, By Applications
    • 5.3.1. Diagnostics
    • 5.3.2. Research
  • 5.4. Global HLA Typing for Transplant Market, ByEnd-Users
    • 5.4.1. Academic Institutes & Research Centers
    • 5.4.2. Hospitals&Transplant Centers
    • 5.4.3. Donor Registries

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World
    • 6.4.1. Latin America
    • 6.4.2. Middle East& Africa

7. Company Profiles

  • 7.1. Biofortuna Ltd.
  • 7.2. Bio-Rad Laboratories, Inc
  • 7.3. Biotron Healthcare Pvt. Ltd.
  • 7.4. Creative-Biolabs Inc.
  • 7.5. F. Hoffmann-La Roche Ltd.
  • 7.6. FujirebioDiagnostics, Inc.
  • 7.7. Genome Diagnostics B.V.
  • 7.8. HistoGenetics LLC
  • 7.9. Illumina, Inc.
  • 7.10. Immucor Inc.
  • 7.11. Integrated Gulf Biosystems
  • 7.12. Luminex Corp.
  • 7.13. MC Diagnostics Ltd.
  • 7.14. Omixon Inc.
  • 7.15. Pacific Biosciences of California, Inc.
  • 7.16. PROIMMUNE LTD.
  • 7.17. Qiagen GmbH
  • 7.18. TBG Diagnostics Ltd.
  • 7.19. Thermo Fisher Scientific Inc.
  • 7.20. Voden Medical Instruments S.p.a.

LIST OF TABLES

  • 1. GLOBAL HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BYTECHNOLOGY, 2020-2027 ($ MILLION)
  • 2. GLOBAL NON-MOLECULAR ASSAYS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL NON-MOLECULAR ASSAYS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 4. GLOBAL MOLECULAR ASSAYS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL MOLECULAR ASSAYS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 6. GLOBAL HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY PRODUCT & SERVICES, 2020-2027 ($ MILLION)
  • 7. GLOBAL REAGENTS FOR HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL SOFTWARE FOR HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL INSTRUMENTS FOR HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
  • 11. GLOBAL HLA TYPING FOR TRANSPLANT IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBALHLA TYPING FOR TRANSPLANT IN RESEARCH MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027 ($ MILLION)
  • 14. GLOBAL HLA TYPING FOR TRANSPLANT IN ACADEMIC INSTITUTES & RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL HLA TYPING FOR TRANSPLANT IN HOSPITALS & TRANSPLANT CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL HLA TYPING FOR TRANSPLANT IN DONOR REGISTRIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 17. NORTH AMERICAN HLA TYPING FOR TRANSPLANTMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 18. NORTH AMERICAN HLA TYPING FOR TRANSPLANTMARKET RESEARCH AND ANALYSIS BYTECHNOLOGY,2020-2027 ($ MILLION)
  • 19. NORTH AMERICAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY PRODUCT & SERVICES, 2020-2027 ($ MILLION)
  • 20. NORTH AMERICAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
  • 21. NORTH AMERICAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027 ($ MILLION)
  • 22. EUROPEAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 23. EUROPEAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BYTECHNOLOGY,2020-2027 ($ MILLION)
  • 24. EUROPEAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BYPRODUCT & SERVICES, 2020-2027 ($ MILLION)
  • 25. EUROPEAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BYAPPLICATIONS, 2020-2027 ($ MILLION)

26. EUROPEAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027 ($ MILLION

  • 27. ASIA-PACIFIC HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 28. ASIA-PACIFIC HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BYTECHNOLOGY, 2020-2027 ($ MILLION)
  • 29. ASIA-PACIFIC HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BYPRODUCT & SERVICES,2020-2027 ($ MILLION)
  • 30. ASIA-PACIFIC HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
  • 31. ASIA-PACIFIC HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027 ($ MILLION)
  • 32. REST OF THE WORLD HLA TYPING FOR TRANSPLANTMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 33. REST OF THE WORLD HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BYTECHNOLOGY, 2020-2027 ($ MILLION)
  • 34. REST OF THE WORLD HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY PRODUCT & SERVICES,2020-2027 ($ MILLION)
  • 35. REST OF THE WORLD HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
  • 36. REST OF THE WORLD HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027 ($ MILLION)

LIST OF FIGURES

1. IMPACT OF COVID-19 ON GLOBAL HLA TYPING FOR TRANSPLANT MARKET, 2020-2027 (% MILLION)

2. IMPACT OF COVID-19 ON GLOBAL HLA TYPING FOR TRANSPLANT MARKET BY SEGMENT, 2020-2027 (% MILLION)

  • 3. RECOVERY OF GLOBAL HLA TYPING FOR TRANSPLANT MARKET, 2020-2027 (%)
  • 4. GLOBAL HLA TYPING FOR TRANSPLANT MARKET SHARE BYTECHNOLOGY,2020 VS 2027 (%)
  • 5. GLOBAL HLA TYPING FOR TRANSPLANT MARKET SHARE BY PRODUCT & SERVICES, 2020 VS 2027 (%)
  • 6. GLOBAL HLA TYPING FOR TRANSPLANT MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 7. GLOBAL HLA TYPING FOR TRANSPLANT MARKET SHARE BY END-USERS, 2020 VS 2027 (%)
  • 8. GLOBAL HLA TYPING FOR TRANSPLANT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. GLOBAL NON-MOLECULAR ASSAYS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL NON-MOLECULAR ASSAYS MARKET SHARE BY TYPE, 2020-2027 ($ MILLION)
  • 11. GLOBAL MOLECULAR ASSAYS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL MOLECULAR ASSAYS MARKET SHARE BY TYPE, 2020-2027 ($ MILLION)
  • 13. GLOBAL REAGENTS FOR HLA TYPING FOR TRANSPLANT MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL SOFTWARE FOR HLA TYPING FOR TRANSPLANT MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL INSTRUMENTS FOR HLA TYPING FOR TRANSPLANT MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL HLA TYPING FOR TRANSPLANT IN DIAGNOSTICS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 17. GLOBAL HLA TYPING FOR TRANSPLANT IN RESEARCH MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 18. GLOBAL HLA TYPING FOR TRANSPLANT IN ACADEMIC INSTITUTES & RESEARCH CENTERS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 19. GLOBAL HLA TYPING FOR TRANSPLANT IN HOSPITALS & TRANSPLANT CENTERS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 20. GLOBAL HLA TYPING FOR TRANSPLANT IN DONOR REGISTRIES MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 21. US HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. CANADA HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
  • 23. UK HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. FRANCE HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. GERMANY HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. ITALY HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. SPAIN HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. REST OF EUROPE HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. INDIA HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
  • 30. CHINA HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
  • 31. JAPAN HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
  • 32. SOUTH KOREA HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
  • 33. REST OF ASIA-PACIFIC HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)

34. REST OF THE WORLD HLA TYPING FOR TRANSPLANT MARKET SIZE, 2021-2027($ MILLION